Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exogenous Melatonin in Intensive Care Unit Chronodisruption: Randomized Controled Trial

NCT03708341 is registered in ClinicalTrials.gov with Saint-Joseph University as lead sponsor.

NCT NCT03708341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03708341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exogenous Melatonin in Intensive Care Unit Chronodisruption: Randomized Controled Trial
Lead sponsor
Saint-Joseph University
Phase
Phase 3
Overall status
Unknown status
Start date
November 15, 2018
Completion date
March 1, 2024
Enrollment
98 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intensive care psychosis, sleep deprivation